nach oben

Current Cardiology Reports

Erschienen in:

14.10.2023 | Cardiometabolic Disease (DM and CV) (CJ Lavie, Section Editor)

Optimum Dose of Resistance Exercise for Cardiovascular Health and Longevity: Is More Better?

verfasst von: Duck-chul Lee, I-Min Lee

Erschienen in: Current Cardiology Reports | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Although there is extensive research on how much aerobic exercise to prescribe in order to reduce the risks of cardiovascular disease (CVD) and premature mortality, there is limited research on how much resistance exercise to prescribe. This review is to help fill important gaps in knowledge on effective minimum dose, beneficial optimum dose, and safe maximum dose of resistance exercise for CVD prevention and longevity.

Recent Findings

In contrast to aerobic exercise where “some is good, more is better," recent observational studies suggested a J-shaped relation where more time in resistance exercise was associated with lower CVD risk and mortality only up to 40–60 min/week, beyond which risk reductions attenuated or even disappeared. While it remains unclear, postulated mechanisms that may underlie the higher CVD risk and mortality with higher resistance exercise doses include increased arterial stiffness and chronic inflammation.

Summary

Current observational data suggest that “more may not be better” for dose-response relations of resistance exercise with CVD and mortality; however, this requires confirmation, especially from randomized controlled trials that directly test and compare multiple doses of resistance exercise. Until these data exist, it is prudent to recommend small doses of resistance exercise for cardiovascular health and longevity.

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010.CrossRefPubMedPubMedCentral

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93–621. https://doi.org/10.1161/CIR.0000000000001123.CrossRefPubMed

2018 Physical Activity Guidelines Advisory Committee. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Retrieved from: https://health.gov/our-work/nutrition-physical-activity/physical-activity-guidelines/current-guidelines/scientific-report. Accessed 2 Sept 2023.

US Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd Edition. Retrieved from: https://health.gov/our-work/nutrition-physical-activity/physical-activity-guidelines. Accessed 2 Sept 2023.

WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization. Retrieved from: https://www.who.int/publications/i/item/9789240015128. Accessed 2 Sept 2023.

Lee DC, Artero EG, Sui X, Blair SN. Mortality trends in the general population: the importance of cardiorespiratory fitness. J Psychopharmacol. 2010;24(4 Suppl):27–35. https://doi.org/10.1177/1359786810382057.CrossRefPubMedPubMedCentral

Moore SC, Patel AV, Matthews CE, de Berrington GA, Park Y, Katki HA, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med. 2012;9(11):e1001335. https://doi.org/10.1371/journal.pmed.1001335.CrossRefPubMedPubMedCentral

Paluch AE, Bajpai S, Bassett DR, Carnethon MR, Ekelund U, Evenson KR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. Lancet Public Health. 2022;7(3):e219–28. https://doi.org/10.1016/S2468-2667(21)00302-9.CrossRefPubMedPubMedCentral

Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378(9798):1244–53. https://doi.org/10.1016/S0140-6736(11)60749-6.CrossRefPubMed

10.

Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014;64(5):472–81. https://doi.org/10.1016/j.jacc.2014.04.058.CrossRefPubMedPubMedCentral

11.

Lee DC, Lavie CJ, Sui X, Blair SN. Running and mortality: is more actually worse? Mayo Clin Proc. 2016;91(4):534–6. https://doi.org/10.1016/j.mayocp.2016.01.013.CrossRefPubMed

12.

Schnohr P, O’Keefe JH, Marott JL, Lange P, Jensen GB. Dose of jogging and long-term mortality: the Copenhagen City Heart Study. J Am Coll Cardiol. 2015;65(5):411–9. https://doi.org/10.1016/j.jacc.2014.11.023.CrossRefPubMed

13.

Eijsvogels TM, Molossi S, Lee DC, Emery MS, Thompson PD. Exercise at the extremes: the amount of exercise to reduce cardiovascular events. J Am Coll Cardiol. 2016;67(3):316–29. https://doi.org/10.1016/j.jacc.2015.11.034.CrossRefPubMed

14.

Ashton RE, Tew GA, Aning JJ, Gilbert SE, Lewis L, Saxton JM. Effects of short-term, medium-term and long-term resistance exercise training on cardiometabolic health outcomes in adults: systematic review with meta-analysis. Br J Sports Med. 2020;54(6):341–8. https://doi.org/10.1136/bjsports-2017-098970.CrossRefPubMed

15.

Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(1):e004473. https://doi.org/10.1161/JAHA.112.004473.CrossRefPubMedPubMedCentral

16.

Costa RR, Buttelli ACK, Vieira AF, Coconcelli L, Magalhaes RL, Delevatti RS, et al. Effect of strength training on lipid and inflammatory outcomes: systematic review with meta-analysis and meta-regression. J Phys Act Health. 2019;16(6):477–91. https://doi.org/10.1123/jpah.2018-0317.CrossRefPubMed

17.

Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44(2):211–21. https://doi.org/10.1007/s40279-013-0110-5.CrossRefPubMed

18.

Huang L, Fang Y, Tang L. Comparisons of different exercise interventions on glycemic control and insulin resistance in prediabetes: a network meta-analysis. BMC Endocr Disord. 2021;21(1):181. https://doi.org/10.1186/s12902-021-00846-y.CrossRefPubMedPubMedCentral

19.

Lopez P, Taaffe DR, Galvao DA, Newton RU, Nonemacher ER, Wendt VM, et al. Resistance training effectiveness on body composition and body weight outcomes in individuals with overweight and obesity across the lifespan: A systematic review and meta-analysis. Obes Rev. 2022;23(5):e13428. https://doi.org/10.1111/obr.13428.CrossRefPubMedPubMedCentral

20.

Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882–8. https://doi.org/10.1001/jama.288.15.1882.CrossRefPubMed

21.

Wang N, Fulcher J, Abeysuriya N, Park L, Kumar S, Di Tanna GL, et al. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants. Lancet Diabetes Endocrinol. 2020;8(1):36–49. https://doi.org/10.1016/S2213-8587(19)30388-2.CrossRefPubMed

22.

Park C, Guallar E, Linton JA, Lee DC, Jang Y, Son DK, et al. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care. 2013;36(7):1988–93. https://doi.org/10.2337/dc12-1577.CrossRefPubMedPubMedCentral

23.

Lee DC, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN. Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol. 2012;59(7):665–72. https://doi.org/10.1016/j.jacc.2011.11.013.CrossRefPubMedPubMedCentral

24.

Brellenthin AG, Bennie JA, Lee DC. Aerobic or muscle-strengthening physical activity: which is better for health? Curr Sports Med Rep. 2022;21(8):272–9. https://doi.org/10.1249/JSR.0000000000000981.CrossRefPubMedPubMedCentral

25.

Williams MA, Haskell WL, Ades PA, Amsterdam EA, Bittner V, Franklin BA, et al. Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2007;116(5):572–84. https://doi.org/10.1161/CIRCULATIONAHA.107.185214.CrossRefPubMed

26.

Borde R, Hortobagyi T, Granacher U. Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med. 2015;45(12):1693–720. https://doi.org/10.1007/s40279-015-0385-9.CrossRefPubMedPubMedCentral

27.

Steib S, Schoene D, Pfeifer K. Dose-response relationship of resistance training in older adults: a meta-analysis. Med Sci Sports Exerc. 2010;42(5):902–14. https://doi.org/10.1249/MSS.0b013e3181c34465.CrossRefPubMed

28.

Berent R, von Duvillard SP, Crouse SF, Sinzinger H, Green JS, Schmid P. Resistance training dose response in combined endurance-resistance training in patients with cardiovascular disease: a randomized trial. Arch Phys Med Rehabil. 2011;92(10):1527–33. https://doi.org/10.1016/j.apmr.2011.04.021.CrossRefPubMed

29.

•• Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. Br J Sports Med. 2022;56(13):755–63. https://doi.org/10.1136/bjsports-2021-105061. Findings from this meta-analysis provide a J-shaped dose-response relation of resistance exercise with CVD risk and mortality.CrossRefPubMed

30.

Bennie JA, Lee DC, Brellenthin AG, De CK. Muscle-strengthening exercise and prevalent hypertension among 1.5 million adults: a little is better than none. J Hypertens. 2020;38(8):1466–73. https://doi.org/10.1097/HJH.0000000000002415.CrossRefPubMed

31.

Bakker EA, Lee DC, Sui X, Eijsvogels TMH, Ortega FB, Lee IM, et al. Association of resistance exercise with the incidence of hypercholesterolemia in men. Mayo Clin Proc. 2018;93(4):419–28. https://doi.org/10.1016/j.mayocp.2017.11.024.CrossRefPubMed

32.

Bakker EA, Lee DC, Sui X, Artero EG, Ruiz JR, Eijsvogels TMH, et al. Association of resistance exercise, independent of and combined with aerobic exercise, with the incidence of metabolic syndrome. Mayo Clin Proc. 2017;92(8):1214–22. https://doi.org/10.1016/j.mayocp.2017.02.018.CrossRefPubMed

33.

Brellenthin AG, Lee DC, Bennie JA, Sui X, Blair SN. Resistance exercise, alone and in combination with aerobic exercise, and obesity in Dallas, Texas, US: a prospective cohort study. PLoS Med. 2021;18(6):e1003687. https://doi.org/10.1371/journal.pmed.1003687.CrossRefPubMedPubMedCentral

34.

• Liu Y, Lee DC, Li Y, Zhu W, Zhang R, Sui X, et al. Associations of resistance exercise with cardiovascular disease morbidity and mortality. Med Sci Sports Exerc. 2019;51(3):499–508. https://doi.org/10.1249/MSS.0000000000001822. This study shows U-shaped associations between resistance exercise and CVD morbidity and mortality and all-cuase mortality.CrossRefPubMedPubMedCentral

35.

Shiroma EJ, Cook NR, Manson JE, Moorthy MV, Buring JE, Rimm EB, et al. Strength training and the risk of type 2 diabetes and cardiovascular disease. Med Sci Sports Exerc. 2017;49(1):40–6. https://doi.org/10.1249/MSS.0000000000001063.CrossRefPubMedPubMedCentral

36.

Failla M, Grappiolo A, Emanuelli G, Vitale G, Fraschini N, Bigoni M, et al. Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects. J Hypertens. 1999;17(8):1117–23. https://doi.org/10.1097/00004872-199917080-00011.CrossRefPubMed

37.

Miyachi M. Effects of resistance training on arterial stiffness: a meta-analysis. Br J Sports Med. 2013;47(6):393–6. https://doi.org/10.1136/bjsports-2012-090488.CrossRefPubMed

38.

Ceciliato J, Costa EC, Azevedo L, Sousa JC, Fecchio RY, Brito LC. Effect of resistance training on arterial stiffness in healthy subjects: a systematic review and meta-analysis. Curr Hypertens Rep. 2020;22(8):51. https://doi.org/10.1007/s11906-020-01065-x.CrossRefPubMed

39.

Zhang Y, Zhang YJ, Ye W, Korivi M. Low-to-moderate-intensity resistance exercise effectively improves arterial stiffness in adults: evidence from systematic review, meta-analysis, and meta-regression analysis. Front Cardiovasc Med. 2021;8:738489. https://doi.org/10.3389/fcvm.2021.738489.CrossRefPubMedPubMedCentral

40.

Jurik R, Zebrowska A, Stastny P. Effect of an acute resistance training bout and long-term resistance training program on arterial stiffness: a systematic review and meta-analysis. J Clin Med. 2021. https://doi.org/10.3390/jcm10163492.CrossRefPubMedPubMedCentral

41.

Ambrosino P, Bachetti T, D’Anna SE, Galloway B, Bianco A, D’Agnano V, et al. Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension. J Cardiovasc Dev Dis. 2022. https://doi.org/10.3390/jcdd9050136.CrossRefPubMedPubMedCentral

42.

Jones DP, True HD, Patel J. Leukocyte trafficking in cardiovascular disease: insights from experimental models. Mediators Inflamm. 2017;2017:9746169. https://doi.org/10.1155/2017/9746169.CrossRefPubMedPubMedCentral

43.

Sun HJ, Wu ZY, Nie XW, Bian JS. Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide. Front Pharmacol. 2019;10:1568. https://doi.org/10.3389/fphar.2019.01568.CrossRefPubMed

44.

Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, et al. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021. https://doi.org/10.3390/biomedicines9070781.CrossRefPubMedPubMedCentral

45.

Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, et al. Exerkines in health, resilience and disease. Nat Rev Endocrinol. 2022;18(5):273–89. https://doi.org/10.1038/s41574-022-00641-2.CrossRefPubMedPubMedCentral

46.

Gonzalez-Gil AM, Elizondo-Montemayor L. The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: a review. Nutrients. 2020. https://doi.org/10.3390/nu12061899.CrossRefPubMedPubMedCentral

47.

Nieman DC, Pence BD. Exercise immunology: future directions. J Sport Health Sci. 2020;9(5):432–45. https://doi.org/10.1016/j.jshs.2019.12.003.CrossRefPubMed

48.

Rosa-Neto JC, Lira FS, Little JP, Landells G, Islam H, Chazaud B, et al. Immunometabolism-fit: How exercise and training can modify T cell and macrophage metabolism in health and disease. Exerc Immunol Rev. 2022;28:29–46. PMID: 35452394.PubMed

49.

Castaneda AB, Petty LE, Scholz M, Jansen R, Weiss S, Zhang X, et al. Associations of carotid intima media thickness with gene expression in whole blood and genetically predicted gene expression across 48 tissues. Hum Mol Genet. 2022;31(7):1171–82. https://doi.org/10.1093/hmg/ddab236.CrossRefPubMed

50.

Miranda AMA, Janbandhu V, Maatz H, Kanemaru K, Cranley J, Teichmann SA, et al. Single-cell transcriptomics for the assessment of cardiac disease. Nat Rev Cardiol. 2023;20(5):289–308. https://doi.org/10.1038/s41569-022-00805-7.CrossRefPubMed

51.

Kim SD, Yeun YR. Effects of resistance training on C-reactive protein and inflammatory cytokines in elderly adults: a systematic review and meta-analysis of randomized controlled trials. Int J Environ Res Public Health. 2022. https://doi.org/10.3390/ijerph19063434.CrossRefPubMedPubMedCentral

52.

Sardeli AV, Tomeleri CM, Cyrino ES, Fernhall B, Cavaglieri CR, Chacon-Mikahil MPT. Effect of resistance training on inflammatory markers of older adults: a meta-analysis. Exp Gerontol. 2018;111:188–96. https://doi.org/10.1016/j.exger.2018.07.021.CrossRefPubMed

53.

Bennie JA, Lee DC, Khan A, Wiesner GH, Bauman AE, Stamatakis E, et al. Muscle-strengthening exercise among 397,423 u.s. adults: prevalence, correlates, and associations with health conditions. Am J Prev Med. 2018;55(6):864–74. https://doi.org/10.1016/j.amepre.2018.07.022.CrossRefPubMed

54.

US Centers for Disease Control and Prevention. Trends in meeting the 2008 physical activity guidelines, 2008–2017. Retrieved from: https://www.cdc.gov/physicalactivity/downloads/trends-in-the-prevalence-of-physical-activity-508.pdf. Accessed 2 Sept 2023.

55.

Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960-1962 through 2017-2018. NCHS Health E-Stats. 2020. Retrieved from: https://www.cdc.gov/nchs/data/hestat/obesity-adult-17-18/obesity-adult.htm. Accessed 2 Sept 2023.

56.

Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. https://doi.org/10.1056/NEJMoa1614362.CrossRefPubMed

57.

Sardeli AV, Komatsu TR, Mori MA, Gaspari AF, Chacon-Mikahil MPT. Resistance training prevents muscle loss induced by caloric restriction in obese elderly individuals: a systematic review and meta-analysis. Nutrients. 2018. https://doi.org/10.3390/nu10040423.CrossRefPubMedPubMedCentral

58.

Schroeder EC, Welk GJ, Franke WD, Lee DC. Associations of health club membership with physical activity and cardiovascular health. PLoS ONE. 2017;12(1):e0170471. https://doi.org/10.1371/journal.pone.0170471.CrossRefPubMedPubMedCentral

59.

Arem H, Moore SC, Patel A, Hartge P, de Berrington GA, Visvanathan K, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175(6):959–67. https://doi.org/10.1001/jamainternmed.2015.0533.CrossRefPubMedPubMedCentral

Titel: Optimum Dose of Resistance Exercise for Cardiovascular Health and Longevity: Is More Better?
verfasst von: Duck-chul Lee
I-Min Lee
Publikationsdatum: 14.10.2023
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 11/2023
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-023-01976-6

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Optimum Dose of Resistance Exercise for Cardiovascular Health and Longevity: Is More Better?

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2023

TAVR in TAVR: Where Are We in 2023 for Management of Failed TAVR Valves?

Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients

Tailored to a Woman’s Heart: Gender Cardio-Oncology Across the Lifespan

Index-Guided High-Power Radiofrequency Catheter Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis Study

Coronary Angiography Complicated by Acute Ischaemic Stroke and the Use of Thrombolysis: a Cardiology Perspective and Narrative Review of Current Literature

Indications for Cardiac Catheterization and Percutaneous Coronary Intervention in Patients with Resuscitated Out-of-Hospital Cardiac Arrest

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie